spacer
home > ebr > spring 2003 > meptides: a novel class of synthetic peptide derivatives for the potential treatment of neurodegenerative diseases
PUBLICATIONS
European Biopharmaceutical Review

Meptides: A Novel Class of Synthetic Peptide Derivatives for the Potential Treatment of Neurodegenerative Diseases

A number of seemingly unrelated neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases, CJD (the human form of 'mad cow' disease) and ALS (motor neurone disease) have all recently been linked to a common pathogenic process called amyloidosis. In each case a specific protein or peptide clumps together in a specific part of the brain to form toxic soluble oligomers and/or insoluble fibres, which are widely believed to cause the progressive degeneration of neurons associated with these diseases. Several academic groups and at least one biotech company are now working on a novel class of synthetic peptide derivatives ('meptides') which can inhibit and reverse this process of protein/peptide aggregation in vitro, and which have the potential to yield effective treatments or perhaps even outright cures for all these diseases.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Kelvin Stott, Chief Scientific Officer, and Andrew J Doig, Research Director, at Senexis Limited

Kelvin Stott is the Chief Scientific Officer and a Co-Founder of Senexis Limited. Before forming Senexis, he gained his PhD and studied the mechanism of Huntington's disease as a Research Fellow at Cambridge University. He then spent two years working in the pharmaceutical sector as a management consultant at McKinsey & Company.


Andrew J Doig is a Senior Lecturer in the Department of Biomolecular Sciences at UMIST and Research Director of Senexis. He undertook research at Cambridge and Stanford Universities before taking a lectureship at UMIST in 1994. His research interests include protein structure and bioinformatics, as well as amyloid.

spacer
Kelvin Stott
spacer
spacer
spacer
Andrew J Doig
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

5th Annual BioPharma Asia Convention 2012

19-22 March 2012, Marina Bay Sands, Singapore

BioPharma Asia Convention is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CMOs, CROs, academic institutions, investors and all other industrial stakeholders to assess the latest industrial trends, partnership models and solutions in Asia.  
More info >>

 
News and Press Releases

DASGIP Product Catalog 2012 now available for download

The new DASGIP Product Catalogue is now available online. The catalogue offers a user-friendly update on our technology. You will find a comprehensive overview on our portfolio including information on recently launched products such as our Bioprocess Software Suite DASware and the Minibioreactor System DASbox.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.